entity

synaptic_loss

Entity Detail — Knowledge Graph Node

Understanding Entity Pages

This page aggregates everything SciDEX knows about synaptic_loss: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.

17Connections

2Hypotheses

14Analyses

5Outgoing

12Incoming

0Experiments

20Debates

No AI portrait yet

Wiki Pages (1)

Knowledge base pages for this entity

Canonical Page

Synaptic Loss in Alzheimer's Disease Pathway

mechanism · 2984 words

→

Outgoing (5)

Target	Relation	Type	Str
Cognitive decline	causes	phenotype	0.90
Cognitive decline	associated_with	phenotype	0.90
alzheimers	associated_with	disease	0.85
Cognitive decline	biomarker_for	phenotype	0.70
DEPRESSION	contributes_to	disease	0.56

Incoming (12)

Source	Relation	Type	Str
mechanisms-synaptic-loss-ad	describes	wiki	0.90
Alzheimer's_disease	causes	disease	0.80
SPP1	causes	gene	0.70
soluble_tau_oligomers	causes	protein	0.70
C1q	causes	protein	0.70
APOE4 fragments	causes	protein	0.70
complement_cascade	causes	pathway	0.70
phagocytosis	causes	phenotype	0.64
PHAGOCYTOSIS	causes	phenotype	0.64
tripartite_synapse_dysfunction	NULL	pathological_process	0.50
Alectinib	inhibits	drug	0.50
tripartite_synapse_dysfunction	causes	pathological_process	0.50

Targeting Hypotheses (2)

Hypotheses where this entity is a therapeutic target

Hypothesis	Score	Disease	Analysis
Excessive C1q/C3/CR3 complement cascade activation initiates	0.720	neurodegeneration	Synaptic pruning by microglia in neurode
Astrocyte Reactivity Mediated by LCN2 Promotes Synaptic Loss	0.508	neurodegeneration	Legacy Pre-Pipeline Hypothesis Import

Mentioning Analyses (14)

Scientific analyses that reference this entity

Does the cancer-cystatin-C-TREM2 pathway protect against tau pathology and other

neurodegeneration | 2026-04-25 | 13 hypotheses Top: 0.867

How does Alectinib, a kinase inhibitor, achieve high-affinity binding to complem

neuroinflammation | 2026-04-16 | 5 hypotheses Top: 0.597

What molecular mechanisms mediate SPP1-induced microglial phagocytic activation

neuroinflammation | 2026-04-15 | 13 hypotheses Top: 0.752

Is C1q elevation in AD pathogenic or compensatory for amyloid clearance?

neurodegeneration | 2026-04-12 | 0 hypotheses

What specific gene expression signatures in aging mouse brain predict human AD v

neurodegeneration | 2026-04-12 | 0 hypotheses

Experiments (0)

Experimental studies targeting or related to this entity

Experiment	Type	Disease	Score	Feasibility	Model	Status	Est. Cost
No experiments found

Related Papers (0)

Scientific publications cited in analyses involving this entity

Title & PMID	Authors	Journal	Year	Citations
No papers found

Debates (20)

Multi-agent debates referencing this entity

Second debate: Microglial TREM2-SYK Pathway Enhancement

closed · Rounds: 4 · Score: 0.57 · 2026-04-28

Debate: LPCAT3-Mediated Lands Cycle Remodeling as the Primary Ferroptotic Primin

closed · Rounds: 4 · Score: 0.12 · 2026-04-27

Debate: ALOX15-Driven Enzymatic Ferroptosis in AD Oligodendrocytes via PUFA-PE P

closed · Rounds: 4 · Score: 0.42 · 2026-04-27

Debate: LPCAT3-Mediated Lands Cycle Amplification of Ferroptotic Vulnerability i

closed · Rounds: 4 · Score: 0.48 · 2026-04-27

Debate: ACSL4-Driven Ferroptotic Priming in Disease-Associated Oligodendrocytes

closed · Rounds: 4 · Score: 0.47 · 2026-04-27

Should '40 Hz Gamma Entrainment Gates ACSL4-Mediated Ferroptotic Priming to Sele

closed · Rounds: 4 · Score: 0.52 · 2026-04-27

Should 'ACSL4-Ferroptotic Priming in Stressed Oligodendrocytes Drives White Matt

closed · Rounds: 4 · Score: 0.72 · 2026-04-27

Does the cancer-cystatin-C-TREM2 pathway protect against tau pathology and other

closed · Rounds: 4 · Score: 0.66 · 2026-04-25

The study shows SPP1 from perivascular cells drives microglial synaptic engulfme

closed · Rounds: 4 · Score: 0.70 · 2026-04-22

While SPP1 absence prevents synaptic loss, it's unclear whether this represents

closed · Rounds: 4 · Score: 0.69 · 2026-04-21

Related Research

Hypotheses and analyses mentioning synaptic_loss in their description or question text

No additional research found

synaptic_loss

Understanding Entity Pages

Wiki Pages (1)

Synaptic Loss in Alzheimer's Disease Pathway

Outgoing (5)

Incoming (12)

Targeting Hypotheses (2)

Mentioning Analyses (14)

Does the cancer-cystatin-C-TREM2 pathway protect against tau pathology and other

How does Alectinib, a kinase inhibitor, achieve high-affinity binding to complem

What molecular mechanisms mediate SPP1-induced microglial phagocytic activation

Is C1q elevation in AD pathogenic or compensatory for amyloid clearance?

What specific gene expression signatures in aging mouse brain predict human AD v

Do tau aggregates represent protective responses or primary pathogenic drivers i

Why does prolonged anesthesia cause both cognitive dysfunction and anxiety throu

Does SPP1-mediated synaptic engulfment represent beneficial clearance or patholo

What molecular mechanisms mediate SPP1-induced microglial phagocytic activation

Cell type vulnerability in Alzheimers Disease (SEA-AD transcriptomic data)

Cell type vulnerability in Alzheimer's Disease (SEA-AD data - v2)

Cell type vulnerability in Alzheimer's Disease (SEA-AD data - v2)

Gene expression changes in aging mouse brain predicting neurodegenerative vulner

Synaptic pruning by microglia in early AD

Experiments (0)

Related Papers (0)

Debates (20)

Second debate: Microglial TREM2-SYK Pathway Enhancement

Debate: LPCAT3-Mediated Lands Cycle Remodeling as the Primary Ferroptotic Primin

Debate: ALOX15-Driven Enzymatic Ferroptosis in AD Oligodendrocytes via PUFA-PE P

Debate: LPCAT3-Mediated Lands Cycle Amplification of Ferroptotic Vulnerability i

Debate: ACSL4-Driven Ferroptotic Priming in Disease-Associated Oligodendrocytes

Should '40 Hz Gamma Entrainment Gates ACSL4-Mediated Ferroptotic Priming to Sele

Should 'ACSL4-Ferroptotic Priming in Stressed Oligodendrocytes Drives White Matt

Does the cancer-cystatin-C-TREM2 pathway protect against tau pathology and other

The study shows SPP1 from perivascular cells drives microglial synaptic engulfme

While SPP1 absence prevents synaptic loss, it's unclear whether this represents

Related Research